Professor of Radiology, University Tex Houston
Radiology
Jeremy J. Erasmus, MB BCH
|
|
Give Review
Jeremy J. Erasmus, MB BCH practices Radiology. He over the years received 3 awards: "America's Top Doctors", "Top Doctors:SE Texas" and "America's Top Doctors for Cancer". Jeremy J. Erasmus, MB BCH is also published. He has 76 publications published. The lastest publication: "Acute Thoracic Findings in Oncologic Patients.' Jeremy Erasmus is registered with Medicare.
Publications
- Acute Thoracic Findings in Oncologic Patients.
- Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management.
- Update in the evaluation of the solitary pulmonary nodule.
- Small cell lung carcinoma: staging, imaging, and treatment considerations.
- Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?
- A Phase I/II Study Combining Erlotinib and Dasatinib for Non-Small Cell Lung Cancer.
- Spindle Epithelial Tumor with Thymus-like Differentiation (SETTLE): A Case Report and Comprehensive Review of the Literature and Treatment Options.
- Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy.
- PET-CT: Current Applications and New Developments in the Thorax.
- Cardiac (18)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.
- The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma.
- Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications.
- Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.
- Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant C...
- Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.
- Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma.
- Low-Sensitivity FDG-PET Studies: Less Common Lung Neoplasms.
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy.
- Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epid...
- Computed Tomography Findings Predicting Invasiveness of Thymoma.
- Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
- Expert opinion: lung cancer staging.
- Follow-up of small (4 mm or less) incidentally detected nodules by computed tomography in oncology patients: a retrospective review.
- Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
- Commentary on "Positron Emission Tomography in the Lung" 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging.
- Lipoid pneumonia: spectrum of clinical and radiologic manifestations.
- Fluorodeoxyglucose uptake predicts survival in a CT screening trial.
- Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population.
- Prognosis and reevaluation of lung cancer by positron emission tomography imaging.
- Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy:...
- CT, positron emission tomography, and MRI in staging lung cancer.
- Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management.
- Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response.
- Positron emission tomography imaging in nonsmall-cell lung cancer.
- Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer.
- PET/CT of esophageal cancer: its role in clinical management.
- Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
- The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response.
- Integrated CT-PET imaging of esophageal cancer: unexpected and unusual distribution of distant organ metastases.
- Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
- Short-term restaging of patients with non-small cell lung cancer receiving chemotherapy.
- Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographi...
- Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm.
- Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging.
- Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy.
- Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging.
- Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
- Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
- Cystic bronchioloalveolar cell carcinoma.
- Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: an unusual CT appearance.
- CT, MR, and PET imaging in staging of non-small-cell lung cancer.
- Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls.
- Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT.
- A patient with new-onset seizure and mediastinal adenopathy.
- Bronchioalveolar cell carcinoma: radiologic appearance and dilemmas in the assessment of response.
- Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis.
- Imaging evaluation in the diagnosis and staging of malignant pleural mesothelioma.
- Teflon injection for vocal cord paralysis: false-positive finding on FDG PET-CT in a patient with non-small cell lung cancer.
- Pericardial "sleeve" recess of right inferior pulmonary vein mimicking adenopathy: computed tomography findings.
- "Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview.
- Anatomy of pericardial recesses on multidetector CT: implications for oncologic imaging.
- Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.
- Pleural effusions in lung transplant recipients: image-guided small-bore catheter drainage.
- Bronchiolitis obliterans syndrome in lung transplant recipients: correlation of computed tomography findings with bronchiolitis obliterans syndrome stage.
- The retrotracheal space: normal anatomic and pathologic appearances.
- Thoracic complications of esophageal disorders.
- Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions.
- Azygoesophageal recess.
- Radiation injury of the lung after three-dimensional conformal radiation therapy.
- Primary thoracic sarcomas.
- Hepatic segments II and III mimicking a lung mass: diagnosis of a normal variant using reformatted multiplanar CT images.
- The role of imaging in malignant pleural mesothelioma.
- High-resolution CT of drug-induced lung disease.
- Drug-induced lung injury.
- Multidetector CT Evaluation of Airway Stents: What the Radiologist Should Know.
Doctors Specialties
- Diagnostic Radiology
- Radiology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
Hospital
-
University of Texas M.D. Anderson Cancer Center -
Duke University Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073611257 |
| Last Name Of The Provider | ERASMUS |
| First Name Of The Provider | JEREMY |
| View All |
Similar Doctors
|
|
Dr. Steven L. Lutzker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard P. Klucznik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marvin H. Chasen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judy U. Ahrar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madelyn P. Vuong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luceil B. North, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Achal Sarna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sheena A. Pimpalwar, MB
This Doctor is OpenDoctor Recommended.
|